Temsunol Capsule

Product Description

Temsunol Capsule is a pharmaceutical formulation containing Tamsulosin hydrochloride as its active component. This medication is presented in convenient capsule form for oral administration.

Indications

Temsunol Capsule is specifically indicated for the management of symptoms related to benign prostatic hyperplasia (BPH) in adult male patients. The medication facilitates urination by relaxing smooth muscles in the prostate and bladder neck, thereby alleviating urinary obstruction symptoms caused by prostate enlargement.

Administration Guidelines

For optimal results, Temsunol Capsule should be swallowed whole with water. The recommended dosing schedule is once daily, preferably taken 30 minutes after the same meal each day to maintain consistent plasma concentrations. The capsule should not be crushed, chewed, or opened.

Mechanism of Action

The therapeutic effect of Temsunol Capsule is achieved through its active ingredient, Tamsulosin hydrochloride, which functions as a selective alpha-1 adrenergic receptor antagonist. By blocking these receptors in the prostate and bladder neck, the medication induces smooth muscle relaxation, resulting in improved urinary flow and symptom relief.

Therapeutic Benefits

Temsunol Capsule offers significant clinical benefits by effectively reducing bothersome urinary symptoms associated with BPH. These include improved urinary stream, decreased urinary frequency and urgency, and relief from discomfort caused by prostate enlargement.

Potential Adverse Effects

Some patients may experience mild and transient side effects during treatment with Temsunol Capsule. Commonly reported reactions include dizziness, cephalalgia, orthostatic hypotension, nasal congestion, ejaculatory dysfunction, and mild gastrointestinal disturbances such as nausea or diarrhea.

Dosing Information

The standard therapeutic dose of Temsunol Capsule is 0.4 mg (one capsule) administered once daily. Strict adherence to the prescribing physician’s instructions is essential. Dosage adjustments should only be made under medical supervision.

Precautions

Temsunol Capsule is contraindicated in female patients and pediatric populations. Patients should disclose their complete medical history, particularly regarding hepatic or renal impairment, and current medication regimen to their healthcare provider. Regular prostate health monitoring and follow-up consultations are recommended during treatment.

Storage Conditions

Maintain Temsunol Capsule at controlled room temperature, protected from humidity and light exposure. Ensure proper storage away from children and pets. Discard any unused medication after the expiration date indicated on the packaging, following local pharmaceutical waste disposal regulations.

This product information serves as general guidance only. For specific medical advice and personalized treatment recommendations regarding Temsunol Capsule, consultation with a qualified healthcare practitioner is strongly advised.